Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis

Published:2019-11-15 Issue:22 Volume:58 Page:3331-3336
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Toyama Shiho¹,Takatani Ayuko¹,Koga Tomohiro¹²,Eguchi Mizuna¹,Okamoto Momoko¹,Tsuji Sosuke¹,Endo Yushiro¹,Shimizu Toshimasa¹³,Sumiyoshi Remi¹,Igawa Takashi¹,Kawashiri Shin-ya¹⁴,Iwamoto Naoki¹,Ichinose Kunihiro¹,Tamai Mami¹,Nakamura Hideki¹,Origuchi Tomoki¹,Furuyama Masako⁵,Tabuchi Maiko⁶,Kobayashi Shinichiro⁷,Kanetaka Kengo⁷,Hashisako Mikiko⁸,Abe Kuniko⁸,Niino Daisuke⁸,Sato Shinya⁹,Miyazaki Yasushi¹⁰,Kawakami Atsushi¹

Affiliation:

1. Department of Immunology and Rheumatology, Unit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan

2. Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan

3. Clinical Research Center, Nagasaki University Hospital, Japan

4. Department of Community Medicine, Unit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan

5. Department of Rheumatology, Nagasaki Kita Hospital, Japan

6. Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan

7. Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan

8. Department of Pathology, Nagasaki University Hospital, Japan

9. Department of Hematology, Nagasaki University Hospital, Japan

10. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/22/58_2782-19/_pdf

Reference20 articles.

1. 1. Tokuhira M, Watanabe R, Nemoto T, et al. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma 53: 616-623, 2012.

2. 2. Rizzi R, Curci P, Delia M, et al. Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26: 1-9, 2009.

3. 3. Mariette X, Cazals-Hatem D, Warszawki J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909-3915, 2002.

4. 4. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007.

5. 5. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91: 20-28, 2013.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methotrexate/prednisolone/tacrolimus;Reactions Weekly;2020-03